4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like With a Collaboration Deal in Place with Merck, Cue Biopharma Plans $60 Million IPO December 18, 2017 <b>BioPharm Executive:</b> What Could Trump's Meltdown Mean for Biotech? August 29, 2017 2 Biotechs That May Disappear by 2020 March 30, 2017
